Isonipecotamides for the treatment of integrin-mediated disorders
US7718673B2 · kind B2 · utility
0Cited by
16References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 2003 |
| Grant date | May 18, 2010 |
| Priority date | — |
| Expiry date | Feb 5, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention is directed to novel isonipecotamide derivatives of Formula (I):which are useful in treating integrin-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.